How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,243 results for

Diarrhea Secondary to Medications

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (IRIS-4) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02120027 Recruitment Status : Terminated (Because of negative results

2014 Clinical Trials

102. Olmesartan, Other Antihypertensives, and Chronic Diarrhea Among Patients Undergoing Endoscopic Procedures: A Case-Control Study. (PubMed)

those whose examination indication was diarrhea, and controls were those whose examination indication was esophageal reflux (EGD) or colorectal cancer screening (colonoscopy). We compared cases with controls with regard to the proportion of those listing olmesartan among their medications. Secondary exposures were the proportion of those taking nonolmesartan ARBs or other antihypertensive medications. We also examined biopsy results to determine whether there were histologic changes associated (...) of celiac disease (P=.61) or microscopic colitis (P=1.0), respectively.Our findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Full Text available with Trip Pro

2014 Mayo Clinic Proceedings

103. Long-Term Medical Management of the Pediatric Patient After Liver Transplantation

Long-Term Medical Management of the Pediatric Patient After Liver Transplantation SPECIAL ARTICLE Long-Term Medical Management of the Pediatric Patient After Liver Transplantation: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Deirdre A. Kelly, 1 John C. Bucuvalas, 2 Estella M. Alonso, 3 Saul J. Karpen, 4 Upton Allen, 5 Michael Green, 6 Douglas Farmer, 7 Eyal Shemesh, 8 and Ruth A. McDonald 9 1 Liver Unit (...) and the American Gastroenterological Association policy statement on the use of medical practice guidelines 2 ; and (4) the experience of the authors in managing children under- going liver transplantation (LT). Intended for use by pediatricians and physicians, these recommendations suggest preferred approaches to the diagnostic, thera- peutic, and preventive aspects of care. They are intended to be ?exible, in contrast to standards of care, which are in?exible policies to be followed in every case. Speci?c

2013 American Association for the Study of Liver Diseases

104. Diarrhea (Diagnosis)

and parasites Leukocyte count pH level: A pH level of 5.5 or less or the presence of reducing substances indicates carbohydrate intolerance, which is usually secondary to viral illness Examination of exudates for presence/absence of leukocytes Cultures: Always culture for Salmonella, Shigella, and Campylobacter spp and Y enterocolitica in the presence of clinical signs of colitis or if fecal leukocytes are present; look for Clostridium difficile in those with diarrhea characterized by colitis and/or bloody (...) self-limited; however, an acute infection can have a protracted course. Management is generally supportive: In most cases, the best option for treatment of acute-onset diarrhea is the early use of oral rehydration therapy (ORT). [ ] Pharmacotherapy Vaccines (eg, rotavirus) can help increase resistance to infection. Antimicrobial and antiparasitic agents may be used to treat diarrhea caused by specific organisms and/or clinical circumstances. Such medications include the following: Cefixime

2014 eMedicine Pediatrics

105. Diarrhea (Treatment)

Diarrhea (Treatment) Diarrhea Treatment & Management: Medical Care, Consultations, Diet Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvOTI4NTk4LXRyZWF0bWVudA== processing > Diarrhea Treatment & Management Updated (...) : Oct 31, 2018 Author: Stefano Guandalini, MD; Chief Editor: Carmen Cuffari, MD Share Email Print Feedback Close Sections Sections Diarrhea Treatment Medical Care In 2003 the Center for Disease Control (CDC) put forth recommendations for the management of acute pediatric diarrhea in both the outpatient and inpatient settings including indication for referral. [ ] Indications for medical evaluation of children with acute diarrhea include the following: Younger than 3 months Weight of less than 8 kg

2014 eMedicine Pediatrics

106. Diarrhea (Overview)

and parasites Leukocyte count pH level: A pH level of 5.5 or less or the presence of reducing substances indicates carbohydrate intolerance, which is usually secondary to viral illness Examination of exudates for presence/absence of leukocytes Cultures: Always culture for Salmonella, Shigella, and Campylobacter spp and Y enterocolitica in the presence of clinical signs of colitis or if fecal leukocytes are present; look for Clostridium difficile in those with diarrhea characterized by colitis and/or bloody (...) self-limited; however, an acute infection can have a protracted course. Management is generally supportive: In most cases, the best option for treatment of acute-onset diarrhea is the early use of oral rehydration therapy (ORT). [ ] Pharmacotherapy Vaccines (eg, rotavirus) can help increase resistance to infection. Antimicrobial and antiparasitic agents may be used to treat diarrhea caused by specific organisms and/or clinical circumstances. Such medications include the following: Cefixime

2014 eMedicine Pediatrics

107. Diarrhea (Follow-up)

J, Horner B, Mutters R, Rodloff AC. Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis. Infect Dis Ther . 2016 Oct 21. . Esposito DH, Holman RC, Haberling DL, Tate JE, Podewils LJ, Glass RI, et al. Baseline estimates of diarrhea-associated mortality among United States children before rotavirus vaccine introduction. Pediatr Infect Dis J . 2011 Nov. 30(11):942-7. . Mehal JM, Esposito DH, Holman RC, Tate JE, Sinden LL, Parashar UD. Risk (...) summary. J Pediatr Gastroenterol Nutr . 2008 May. 46(5):619-21. . [Guideline] Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol . 2009 Oct. 104(10):2596-604; quiz 2605. . Kling J. Green Tea and Pomegranate Extract Help Fight Diarrhea in Children. Medscape Medical News. Available at . Accessed: October 24, 2014. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol . 2011 Nov. 45 Suppl:S149-53. . Ruiz-Palacios GM

2014 eMedicine Pediatrics

108. Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial

Posted : April 10, 2015 Sponsor: Chengdu University of Traditional Chinese Medicine Collaborator: Guang'anmen Hospital of China Academy of Chinese Medical Sciences Information provided by (Responsible Party): Chengdu University of Traditional Chinese Medicine Study Details Study Description Go to Brief Summary: This trial is to assess the effectiveness of three types of acupuncture for patients with functional diarrhea comparing to a positive drug control. Condition or disease Intervention/treatment (...) Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2011 Clinical Trials

109. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly 1 AACE Guidelines Laurence Katznelson, MD; John L. D. Atkinson, MD; David M. Cook, MD, FACE; Shereen Z. Ezzat, MD, FRCPC; Amir H. Hamrahian, MD, FACE; Karen K. Miller, MD American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically developed statements to assist health care professionals in medical decision (...) making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may

2011 American Association of Clinical Endocrinologists

110. Medical Work-Up of Uveitis

Medical Work-Up of Uveitis Medical Work-Up of Uveitis – Clinical Correlations Search Medical Work-Up of Uveitis February 16, 2011 6 min read By Mary Whitman, MD Faculty Peer Reviewed Clinical question: What should the medical work-up be for an adult newly diagnosed with uveitis? Uveitis, defined as intraocular inflammation of the eye, can be idiopathic and limited to the eyes, or can be a manifestation of systemic inflammatory diseases and infectious diseases. . However, uveitis (...) . The term “panuveitis” is used when more than one area is involved. Clinical course is defined as acute, chronic, or . These distinctions are important, as different presentations of uveitis are associated with different systemic diseases, and should guide further investigations. The most important first step for all patients with uveitis is a complete, detailed history and full physical exam. In many patients, there will be other signs or symptoms of systemic disease, such as joint pain, diarrhea

2011 Clinical Correlations

111. Efficacy and Safety of Medication Used to Stimulate Ovulation

Efficacy and Safety of Medication Used to Stimulate Ovulation Efficacy and Safety of Medication Used to Stimulate Ovulation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy and Safety of Medication (...) levels [ Time Frame: 2-4 weeks post IVF procedure ] Ongoing pregnancy rate [ Time Frame: 9 months post IVF procedure ] Miscarriage rate [ Time Frame: 9 months post procedure ] Ovarian hyperstimulation syndrome [ Time Frame: 7 days post IVF procedure ] Mild OHSS: Grade 1: Abdominal distention, Ovaries <6 cm Grade 2: Abdominal distention and nausea, vomiting and diarrhea, Ovaries <6 cm Moderate OHSS: a) Grade 3: Grade II criteria and ultrasound ascites/weight gain, Ovaries 6-12 cm Severe OHSS: Grade 4

2016 Clinical Trials

112. Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)

or < 80 with symptoms • Maternal side effects such as nausea, vomiting, diarrhea that cannot be managed with oral medication Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information (...) Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD) Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2016 Clinical Trials

113. Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia. (PubMed)

and epidemiological model to propose an assessment of the burden of medical impoverishment in Ethiopia, i.e., the number of households crossing a poverty line due to excessive OOP direct medical expenses. We utilized disease-specific mortality estimates from the Global Burden of Disease study, epidemiological and cost inputs from surveys, and secondary data from the literature to produce a count of poverty cases due to OOP direct medical costs per specific condition.In Ethiopia, in 2013, and among 20 leading (...) causes of mortality, we estimated the burden of impoverishment due to OOP direct medical costs to be of about 350,000 poverty cases. The top three causes of medical impoverishment were diarrhea, lower respiratory infections, and road injury, accounting for 75 % of all poverty cases.We present a preliminary attempt for the estimation of the burden of medical impoverishment by cause for high mortality conditions. In Ethiopia, medical impoverishment was notably associated with illness occurrence

Full Text available with Trip Pro

2016 BMC Medicine

114. Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation

or chemotherapy [ Time Frame: week 1-9 ] Registered Dietitian assessed respect of the preview protocol treatment each week (radiotherapy and chemotherapy) if not respected: diarrhea is it involved. For patients that received chemotherapy, a weekly blood profile was obtained and study pills were discontinued if neutrophil count became ≤1.5 X 10(9)/L. Secondary objective were to assess whether intake of Bifilact® decreased or delayed the consumption of anti-diarrheal medication [ Time Frame: day 1-60 ] Patients (...) were asked to note, each day during the treatment,in a daily logbook intake of anti-diarrheal medication, laxatives, and antibiotics. The Registered Dietitian assessed symptoms noted with the patient each week.The duration of daily logbook was 4-9 weeks depending of the total dose of external radiotherapy Secondary objectives were to assess whether intake of Bifilact® reduced abdominal pain [ Time Frame: day 1-60 ] Abdominal pain was evaluated according to the NCI scale version 3.0: Grade 1 = mild

2013 Clinical Trials

115. Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01855711

2013 Clinical Trials

116. A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)

A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01870895 Recruitment Status

2013 Clinical Trials

117. Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

difficile. Has a colostomy. Intraabdominal surgery within the last 60 days. Evidence of active, severe colitis. History of short gut syndrome or motility disorders. Requires the regular use of medications that affect bowel motility (e.g., metoclopramide, narcotics, loperamide). Planned therapy in the next 3 months that may cause diarrhea (e.g., chemotherapy). Planned surgery requiring perioperative antibiotics within 6 months of study enrollment. Life expectancy of < 12 months. Compromised immune system (...) Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2013 Clinical Trials

118. A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01896583 Recruitment Status : Completed First Posted : July 11, 2013 Last

2013 Clinical Trials

119. Nutritional Management of Children With Chronic Diarrhea

Summary: The study objective is to assess the growth, tolerance and efficacy of a complete amino acid-based medical food in children with chronic diarrhea. Condition or disease Intervention/treatment Phase Growth and Tolerance Infant Study Other: Experimental Infant Formula Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 19 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary (...) Nutritional Management of Children With Chronic Diarrhea Nutritional Management of Children With Chronic Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Nutritional Management of Children

2013 Clinical Trials

120. Risk Factors for Crohn's Disease of the Neo-Small Intestine in Ulcerative Colitis Patients with Total Proctocolectomy and Primary or Secondary Ileostomies. (PubMed)

trying of ileal pouch) and secondary ileostomy (SI, i.e., stoma created after pouch failure) and to evaluate factors associated with the development of CD of the neo-small intestine proximal to ileostomy.A total of 123 eligible patients were identified from our Pouch Center Registry (PI group, n = 57 and SI group, n = 66). Demographics, clinical features and outcomes (CD of theneo-small intestine, non-CD related strictures, requirement of CD-related medications use, ileostomy-associated (...) Risk Factors for Crohn's Disease of the Neo-Small Intestine in Ulcerative Colitis Patients with Total Proctocolectomy and Primary or Secondary Ileostomies. De novo Crohn’s disease (CD) of the neo-small intestine in ulcerative colitis (UC) patients after total proctocolectomy (TPC) is a new disease entity, which may persist even after a secondary diverting permanent ileostomy for pouch failure. We sought to compare outcomes of primary ileostomy (PI, i.e., stoma created after colectomy without

Full Text available with Trip Pro

2014 Journal of Crohn's & colitis

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>